𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents

✍ Scribed by N.D. Sonawane; Chatchai Muanprasat; Ray Nagatani Jr.; Yuanlin Song; A.S. Verkman


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
218 KB
Volume
94
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy of tumoricidal agents in vitro
✍ Mr J. G. Docherty; J. R. McGregor; C. A. Purdie; D. J. Galloway; P. J. O'Dwyer πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 343 KB πŸ‘ 1 views
Prediction of rodent carcinogenicity uti
✍ Byung Soo Kim; Barry H. Margolin πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 58 KB πŸ‘ 2 views

The primary purpose of this study is to investigate the degree to which we can improve the prediction of rodent carcinogenicity (CA) by combining results from an in vitro and two in vivo genotoxicity tests. We used the Ames Salmonella assay (SAL) for the in vitro test and the micronucleus assay (MNC

Efficacy of a p38 mitogen activated prot
✍ T. Ma; P.-G. Ren; D. M. Larsen; E. Suenaga; S. Zilber; M. Genovese; R. L. Smith; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 174 KB

## Abstract The inhibitor of p38 mitogen‐activated protein kinase (MAPK) is of interest in the nonoperative treatment of periprosthetic osteolysis due to wear particles. Previous studies demonstrated that an oral p38 MAPK inhibitor did not suppress bone formation when given during the initial phase